(Q39439105)

12 September 2017

(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry (English)

1 reference

12 September 2017

0 references

1 reference

8

1 reference

12 September 2017

10

Karin Séron

0 references

Sandrine Belouzard

object named as

Sandrine Belouzard

series ordinal

3

0 references

Yves Rouillé

object named as

Yves Rouillé

series ordinal

9

0 references

Didier Hober

series ordinal

7

object named as

Didier Hober

1 reference

12 September 2017

5

Gilles Duverlie

1 reference

12 September 2017

4

Czeslaw Wychowski

1 reference

12 September 2017

6

Véronique Descamps

1 reference

12 September 2017

2

Anna Albecka

1 reference

12 September 2017

1

Noémie Calland

1 reference

PubMed ID

22105803

12 September 2017

language of work or name

English

0 references

publication date

1 March 2012

1 reference

12 September 2017

1 reference

12 September 2017

55

1 reference

12 September 2017

720-729

1 reference

12 September 2017

3

1 reference

Global epidemiology of hepatitis C virus infection

12 September 2017

1 reference

Treating viral hepatitis C: efficacy, side effects, and complications

21 January 2018

1 reference

New direct-acting antivirals' combination for the treatment of chronic hepatitis C.

21 January 2018

1 reference

Resistance to direct antiviral agents in patients with hepatitis C virus infection

21 January 2018

1 reference

Recent advances in hepatitis C virus cell entry

21 January 2018

1 reference

Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis

21 January 2018

1 reference

Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies

21 January 2018

1 reference

Tea polyphenols for health promotion

21 January 2018

1 reference

Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy

21 January 2018

1 reference

Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus

21 January 2018

1 reference

Antiviral effect of catechins in green tea on influenza virus

21 January 2018

1 reference

Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells

21 January 2018

1 reference

Epigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDL

21 January 2018

1 reference

Characterization of monoclonal antibodies to bovine viral diarrhoea virus: evidence of a neutralizing activity against gp48 in the presence of goat anti-mouse immunoglobulin serum

21 January 2018

1 reference

Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins

21 January 2018

1 reference

Identification of GBF1 as a Cellular Factor Required for Hepatitis C Virus RNA Replication

21 January 2018

1 reference

The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry

21 January 2018

1 reference

Characterization of functional hepatitis C virus envelope glycoproteins.

21 January 2018

1 reference

Expression of the zinc-finger antiviral protein inhibits alphavirus replication

21 January 2018

1 reference

Identification of basic amino acids at the N-terminal end of the core protein that are crucial for hepatitis C virus infectivity

21 January 2018

1 reference

Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus

21 January 2018

1 reference

TaqMan amplification system with an internal positive control for HCV RNA quantitation

21 January 2018

1 reference

Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses

21 January 2018

1 reference

A novel small molecule inhibitor of hepatitis C virus entry

21 January 2018

1 reference

Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission

21 January 2018

1 reference

Multiple effects of silymarin on the hepatitis C virus lifecycle

21 January 2018

1 reference

Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin

21 January 2018

1 reference

Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor

21 January 2018

1 reference

Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding

21 January 2018

1 reference

Inhibition of the infectivity of influenza virus by tea polyphenols

21 January 2018

1 reference

Hepatitis C and liver transplantation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HEP.24803

1 reference

12 September 2017

1 reference

PubMed ID

22105803